Cargando…

Using Machine Learning Modeling to Explore New Immune-Related Prognostic Markers in Non-Small Cell Lung Cancer

OBJECTIVE: To find new immune-related prognostic markers for non-small cell lung cancer (NSCLC). METHODS: We found GSE14814 is related to NSCLC in GEO database. The non-small cell lung cancer observation (NSCLC-OBS) group was evaluated for immunity and divided into high and low groups for differenti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Jiasheng, Nie, Han, He, Jiarui, Wang, Xinlu, Liao, Kaili, Tu, Luxia, Xiong, Zhenfang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7665579/ https://www.ncbi.nlm.nih.gov/pubmed/33215029 http://dx.doi.org/10.3389/fonc.2020.550002

Ejemplares similares

Screening differentially expressed genes of pancreatic cancer between Mongolian and Han people using bioinformatics technology
por: Xu, Jiasheng, et al.
Publicado: (2020)

Efficacy of Immune Checkpoint Inhibitors in Non-small-cell Lung Cancer Patients With Different Metastatic Sites: A Systematic Review and Meta-Analysis
por: Yang, Kaili, et al.
Publicado: (2020)

Exploration of the Immunotyping Landscape and Immune Infiltration-Related Prognostic Markers in Ovarian Cancer Patients
por: Zhao, Na, et al.
Publicado: (2022)

Identifying diagnostic markers and constructing a prognostic model for small-cell lung cancer based on blood exosome-related genes and machine-learning methods
por: Zhang, Kun, et al.
Publicado: (2022)

Machine Learning for Endometrial Cancer Prediction and Prognostication
por: Bhardwaj, Vipul, et al.
Publicado: (2022)

A novel machine learning-based programmed cell death-related clinical diagnostic and prognostic model associated with immune infiltration in endometrial cancer
por: Xiong, Jian, et al.
Publicado: (2023)

Combined bioinformatics technology to explore pivot genes and related clinical prognosis in the development of gastric cancer
por: Xu, Jiasheng, et al.
Publicado: (2021)

Immune Checkpoint Markers in Neuroendocrine Carcinoma of the Digestive System
por: Xing, Jiazhang, et al.
Publicado: (2020)

Development and Validation of a 12-Gene Immune Relevant Prognostic Signature for Lung Adenocarcinoma Through Machine Learning Strategies
por: Xue, Liang, et al.
Publicado: (2020)

Tumor Immune Microenvironment Characteristics and Their Prognostic Value in Non-Small-Cell Lung Cancer
por: Su, Dan, et al.
Publicado: (2021)

Identification of the novel prognostic biomarker, MLLT11, reveals its relationship with immune checkpoint markers in glioma
por: Chen, Long, et al.
Publicado: (2022)

Radiomic Machine-Learning Classifiers for Prognostic Biomarkers of Head and Neck Cancer
por: Parmar, Chintan, et al.
Publicado: (2015)

A prognostic system for epithelial ovarian carcinomas using machine learning
por: Grimley, Philip M., et al.
Publicado: (2021)

Identification of the mitophagy-related diagnostic biomarkers in hepatocellular carcinoma based on machine learning algorithm and construction of prognostic model
por: Tu, Dao-yuan, et al.
Publicado: (2023)

Improved characterization of the relationship between long intergenic non‐coding RNA Linc00152 and the occurrence and development of malignancies
por: Xu, Jiasheng, et al.
Publicado: (2019)

Machine-learning based investigation of prognostic indicators for oncological outcome of pancreatic ductal adenocarcinoma
por: Chang, Jeremy, et al.
Publicado: (2022)

Gustave Roussy immune score is a prognostic marker in patients with small cell lung cancer undergoing immunotherapy: a real-world retrospective study
por: Shangguan, Jian, et al.
Publicado: (2023)

The Machine Learning Model for Distinguishing Pathological Subtypes of Non-Small Cell Lung Cancer
por: Zhao, Hongyue, et al.
Publicado: (2022)

Machine learning in non-small cell lung cancer radiotherapy: A bibliometric analysis
por: Zhang, Jiaming, et al.
Publicado: (2023)

Prediction of bone metastasis in non-small cell lung cancer based on machine learning
por: Li, Meng-Pan, et al.
Publicado: (2023)

Glycosylated Cathepsin V Serves as a Prognostic Marker in Lung Cancer
por: Yang, Lewei, et al.
Publicado: (2022)

Exploration of a Novel Prognostic Risk Signature and Its Effect on the Immune Response in Nasopharyngeal Carcinoma
por: Zhao, Shuang, et al.
Publicado: (2021)

GMFG Has Potential to Be a Novel Prognostic Marker and Related to Immune Infiltrates in Breast Cancer
por: Yang, Yan, et al.
Publicado: (2021)

A Novel Prognostic Scoring System of Intrahepatic Cholangiocarcinoma With Machine Learning Basing on Real-World Data
por: Li, Zhizhen, et al.
Publicado: (2021)

Development and Validation of a Machine Learning Prognostic Model for Hepatocellular Carcinoma Recurrence After Surgical Resection
por: Huang, Yao, et al.
Publicado: (2021)

Incremental value of radiomics with machine learning to the existing prognostic models for predicting outcome in renal cell carcinoma
por: Xing, Jiajun, et al.
Publicado: (2023)

Corrigendum: Machine learning in non-small cell lung cancer radiotherapy: a bibliometric analysis
por: Zhang, Jiaming, et al.
Publicado: (2023)

Explainable Machine Learning Model to Prediction EGFR Mutation in Lung Cancer
por: Yang, Ruiyuan, et al.
Publicado: (2022)

PRLHR Immune Genes Associated With Tumor Mutation Burden can be Used as Prognostic Markers in Patients With Gliomas
por: Liu, Yi, et al.
Publicado: (2022)

Prognostic Value of the Lung Immune Prognostic Index May Differ in Patients Treated With Immune Checkpoint Inhibitor Monotherapy or Combined With Chemotherapy for Non-small Cell Lung Cancer
por: Wang, Wenxian, et al.
Publicado: (2020)

Machine learning-based neddylation landscape indicates different prognosis and immune microenvironment in endometrial cancer
por: Li, Yi, et al.
Publicado: (2023)

Prognostic Implications of Molecular Subtypes in Primary Small Cell Lung Cancer and Their Correlation With Cancer Immunity
por: Qi, Jing, et al.
Publicado: (2022)

Identifying tumor antigens and immune subtypes of gastrointestinal MALT lymphoma for immunotherapy development
por: Jiang, Xinlu, et al.
Publicado: (2022)

Platelet–lymphocyte ratio is a prognostic marker in small cell lung cancer—A systemic review and meta-analysis
por: Zhou, Hongbin, et al.
Publicado: (2023)

Identifying Prognostic Markers From Clinical, Radiomics, and Deep Learning Imaging Features for Gastric Cancer Survival Prediction
por: Hao, Degan, et al.
Publicado: (2022)

The Expression and Prognostic Impact of Immune Cytolytic Activity-Related Markers in Human Malignancies: A Comprehensive Meta-analysis
por: Roufas, Constantinos, et al.
Publicado: (2018)

AMPD1 Is Associated With the Immune Response and Serves as a Prognostic Marker in HER2-Positive Breast Cancer
por: Wang, Long, et al.
Publicado: (2021)

B7H6 Serves as a Negative Prognostic Marker and an Immune Modulator in Human Pancreatic Cancer
por: Zhu, Zheng, et al.
Publicado: (2022)

Differentially Expressed Genes in Clear Cell Renal Cell Carcinoma as a Potential Marker for Prognostic and Immune Signatures
por: Tong, Ying, et al.
Publicado: (2021)

The gene regulatory molecule GLIS3 in gastric cancer as a prognostic marker and be involved in the immune infiltration mechanism
por: Ding, Yi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_eq7agmjccdmeg7qj0i05r78jv3